Chugai Pharmaceutical Co., Ltd.
Total Valuation
EURAs of June 30, 2026, Chugai Pharmaceutical Co., Ltd. carries a market capitalization of 66.91B, placing it among publicly traded companies globally. Its enterprise value stands at 61.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 66.91B |
| Enterprise Value | 61.73B |
Important Dates
Chugai Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for October 27, 2026.
| Earnings Date | 10/27/2026 |
Share Statistics
As of June 30, 2026, Chugai Pharmaceutical Co., Ltd. has 1.65B shares outstanding.
| Shares Outstanding | 1.65B |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 6.13 |
| P/TBV Ratio | 6.31 |
Financial Position
As of June 30, 2026, Chugai Pharmaceutical Co., Ltd. maintains a current ratio of 4.35, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.35 |
| Quick Ratio | 2.45 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 7,848.50 |
Stock Price Statistics
EURAs of the close on October 22, 2026, Chugai Pharmaceutical Co., Ltd.'s stock has declined approximately 10.16% over the past 52 weeks. The 50-day moving average sits at 35.59, while the 200-day moving average is 42.07.
| 52-Week Price Change | -10.16% |
| 50-Day Moving Average | 35.59 |
| 200-Day Moving Average | 42.07 |
Balance Sheet
EURThese figures are as of June 30, 2026. Total book value stands at 10.92B, with working capital of 7.06B providing operational flexibility.
| Cash & Cash Equivalents | 5.18B |
| Net Debt | -2.10B |
| Equity (Book Value) | 10.92B |
| Book Value Per Share | 6.63 |
| Working Capital | 7.06B |
Stock Splits
Chugai Pharmaceutical Co., Ltd.'s most recent stock split took place on June 29, 2020 with a 1:3 split ratio.
| Last Split Date | 6/29/2020 |
| Split Ratio | 1:3 |